A Phase I Study of SIM0388 in Participants With Malignant Ascites.

NCT07007988 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Ascites

Interventions

DRUG: SIM0388
DRUG: SIM0388

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.